logo

ENTERO vs SWIGGY: Stock Comparison

ENTERO HEALTHCARE SOLU L vs SWIGGYUpdated 19 Oct 26, 4:08 PM ISTNSE & company filings

SWIGGY is the larger company by market capitalisation. ENTERO HEALTHCARE SOLU L shows a higher net margin, while SWIGGY shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ENTERO leads 4; SWIGGY leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ENTEROSWIGGY

Valuation lens

What price are you paying?

Market CapContext only
₹6,558 Cr
₹63,156 Cr
P/E RatioSWIGGY has the lower reading
52.28x
0x ✓
P/B RatioSWIGGY has the lower reading
3.88x
3.45x ✓
EPSENTERO has the higher reading
₹8.77 ✓
₹-2.87
Book ValueContext only
₹402.67
₹66.35
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SWIGGY is the larger company
₹63,156 Cr vs ₹6,558 Cr
P/E Ratio
SWIGGY has a lower P/E
0x vs 52.28x
P/B Ratio
SWIGGY has a lower P/B
3.45x vs 3.88x
EPS
ENTERO has higher earnings per share
₹8.77 vs ₹-2.87
Revenue Growth (TTM YoY)
SWIGGY has faster revenue growth
44.7% vs 42.6%
EPS Growth (TTM YoY)
ENTERO has faster EPS growth
9.1% vs 0%
ROE
SWIGGY has a higher ROE
2% vs 1.6%
ROCE
SWIGGY has a higher ROCE
2.3% vs 2.01%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricENTEROSWIGGY
SectorConsumer ServicesConsumer Services
IndustryPharmacy RetailE-Retail/ E-Commerce

Price

MetricENTEROSWIGGY
Live Price₹1,503.9₹229
Day Change-5.12%-2.26%
Volume1.65 L48 L
52-Week High₹1,920₹435.9
52-Week Low₹944₹228.45
Distance from 52W High-21.67%-47.47%

Valuation

MetricENTEROSWIGGY
Market Cap₹6,558 Cr₹63,156 Cr
P/E Ratio52.28x0x
P/B Ratio3.88x3.45x
EPS₹8.77₹-2.87
Book Value₹402.67₹66.35
Dividend Yield0%0%

Growth

MetricENTEROSWIGGY
Revenue Growth (TTM YoY)42.6%44.7%
EPS Growth (TTM YoY)9.1%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricENTEROSWIGGY
ROE1.6%2%
ROCE2.01%2.3%
Net Margin1.75%-18.02%
Operating Margin9.99%5.29%
Debt to Equity0.06x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricENTEROSWIGGY
Promoter Holding14.4%▼ 0.01 pp—
FII Holding4.37%▲ 0.34 pp8.86%▼ 5.1 pp
DII Holding15.48%▼ 1.14 pp34.49%▲ 7.11 pp
Public Holding27.75%▲ 0.82 pp51.67%▼ 1.9 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ENTERO HEALTHCARE SOLU L and SWIGGY.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.